Galapagos NV GLPG

Updated: 16 Jun 2026

NASDAQ | Biotech | Biotechnology and drug development

No signal published yet

We already track Galapagos NV and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Galapagos NV free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and drug development
We're already tracking Galapagos NV — here are the latest events we've registered

Recent News

  • In May 2024, Galapagos presented Phase 1 data for its CAR-T candidate GLPG5101 at the ASCO Annual Meeting, demonstrating a 100% objective response rate in non-Hodgkin lymphoma. The company is currently expanding its decentralized manufacturing network to support its clinical oncology programs.

What Firelda Watch includes for Galapagos NV

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Galapagos NV will be delivered in the same format.

Want to follow Galapagos NV? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Galapagos NV free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Galapagos NV GLPG
Galapagos NV — follow and we'll monitor it
Follow Galapagos NV free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.